1 long-form article and 1 pre-market mention covering $BMY from AskMelon Research.
Pfizer just printed a clean beat — $14.45 billion in Q1 2026 revenue, up 5.4%, an adjusted EPS of $0.75 that topped consensus, and management reaffirming full-year guidance of $59.5–62.5 billion. Read…
Palantir's after-hours blowout — EPS $0.41 vs $0.35 est, revenue $1.94B (+93% YoY), full-year guide raised $500M to $8.15–8.16B — has NQ futures +0.60% and XLK pre-market +1.22%, but the real stakes a…